Lingling Li

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 655 citations · Full text

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Sebastian Grosicki, Maryana Simonova, Ivan Špıčka et al. · The Lancet · 2020 · 310 citations · Full text

Hematological Malignancy, Once-per-week Selinexor, Medicine +7

PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling

Zhongyi Fan, Jingjing Duan, Lingxiong Wang et al. · Cancer Letters · 2019 · 105 citations

Cancer Research, Signaling Pathway, Medicine +10

Absence of associations between influenza vaccines and increased risks of seizures, Guillain–Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season

Alison Tse Kawai, Lingling Li, Martin Kulldorff et al. · Pharmacoepidemiology and Drug Safety · 2014 · 51 citations

Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease

Jie Yang, Chuanmei Liu, Lingling Li et al. · Canadian Respiratory Journal · 2019 · 36 citations · Full text